Cardiac Shock Wave Therapy in Cardiovascular Diseases

Review Article | Vol 3 | Issue 2 | July-December 2023 | page: 81-86 | Na Chen, Hanhua Ji

DOI: https://doi.org/10.13107/jrs.2023.v03.i02.115

Author: Na Chen [1], Hanhua Ji [2]

[1] Department of Internal Medicine, Peking University Hospital, Beijing 100871, China.
[2] Department of Cardiovascular Medicine, Peking University Civil Aviation General Hospital, Beijing 100123, China.

Address of Correspondence

Dr. Na Chen,
Department of Internal Medicine, Peking University Hospital, Beijing 100871, China.
E-mail: 18901267905@163.com

Abstract

Cardiovascular disease is one of the leading causes of death worldwide, placing a huge burden on patients and healthcare systems. Cardiac shock wave (CSW) technology is a non-invasive treatment method. In recent years, some scholars have discovered that extracorporeal shock wave can improve cardiovascular ischemic lesions. This article reviews the latest progress in basic research and clinical application of cardiac shock wave technology in cardiovascular medicine and reviews its efficacy and potential mechanisms in different diseases. First, the principle of shock waves and their application potential in cardiovascular medicine are introduced. Then, from the aspects of basic research and clinical application, the mechanism and clinical efficacy of shock waves in cardiovascular diseases such as coronary heart disease, myocardial ischemia-reperfusion injury, atrial fibrillation, atherosclerosis, and coronary artery calcification are discussed, as well as its advantages and limitations. Animal experiments and clinical studies have found that low-energy extracorporeal shock waves can upregulate the expression of vascular endothelial
growth factors, promote angiogenesis, promote nitric oxide production, increase local blood perfusion, significantly reduce angina symptoms, and improve left ventricular function and remodeling. Finally, the future development trend of shock wave technology is prospected. This review provides an introduction to the properties, biomechanical effects, treatment mechanisms of cardiovascular diseases, research status and development prospects of extracorporeal shock waves.
Keywords: Cardiac shock Wave Therapy, Cardiovascular diseases, ESWT

References:

1. Yeates K, Lohfeld L, Sleeth J, et al. A global perspective on cardiovascular disease in vulnerable populations. Canadian Journal of Cardiology, 2015, 31(9): 1081-1093.
2. Burneikaitė G, Shkolnik E, Čelutkienė J, et al. Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis. Cardiovascular ultrasound, 2017, 15: 1-13.
3. Wang Y, Guo T, Ma T, et al. A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. Cardiovascular Ultrasound, 2012, 10: 1-10.
4. Yang H T, Xie X, Hou X G, et al. Cardiac shock wave therapy for coronary heart disease: an updated meta-analysis. Brazilian Journal of Cardiovascular Surgery, 2020, 35: 741-756.
5. Jia N, Zhang R, Liu B, et al. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: a randomized, double-blind control study. Journal of Nuclear Cardiology, 2021: 1-16.
6. Di Meglio F, Nurzynska D, Castaldo C, et al. Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration. Journal of cellular and molecular medicine, 2012, 16(4): 936-942.
7. Wu X, Gu M, Ma Y, et al. Observation of the effectiveness of clinical indicators of cardiac shock wave therapy in patients with ischemic heart disease: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 2023, 10: 1088811.
8. Shrivastava S K, Kailash. Shock wave treatment in medicine. Journal of biosciences, 2005, 30: 269-275.
9. Zhang Q, Liu L, Sun W, et al. Extracorporeal shockwave therapy in osteonecrosis of femoral head: a systematic review of now available clinical evidences. Medicine, 2017, 96(4).
10. Karimi Galougahi K, Patel S, Shlofmitz R A, et al. Calcific plaque modification by acoustic shock waves: intravascular lithotripsy in coronary interventions. Circulation: Cardiovascular Interventions, 2021, 14(1): e009354.
11. Wang M, Yang D, Hu Z, et al. Extracorporeal Cardiac Shock Waves Therapy Improves the Function of Endothelial Progenitor Cells After Hypoxia Injury via Activating PI3K/Akt/eNOS Signal Pathway. Frontiers in Cardiovascular Medicine, 2021, 8: 747497.
12. Shao P L, Chiu C C, Yuen C M, et al. Shock wave therapy effectively attenuates inflammation in rat carotid artery following endothelial denudation by balloon catheter. Cardiology, 2010, 115(2): 130-144.
13. Fukumoto Y, Ito A, Uwatoku T, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coronary artery disease, 2006, 17(1): 63-70.
14. Peng Y Z, Zheng K, Yang P, et al. Shock wave treatment enhances endothelial proliferation via autocrine vascular endothelial growth factor. Genet Mol Res, 2015, 14(4): 19203-19210.
15. Petrusca L, Croisille P, Augeul L, et al. Cardioprotective effects of shock wave therapy: A cardiac magnetic resonance imaging study on acute ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine, 2023, 10: 1134389.
16. Qiu Q, Shen T, Yu X, et al. Cardiac shock wave therapy alleviates hypoxia/reoxygenation-induced myocardial necroptosis by modulating autophagy. BioMed Research International, 2021, 2021.
17. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. American Journal of Cardiovascular Drugs, 2011, 11: 295-302.
18. Wong B, El-Jack S, Newcombe R, et al. Shockwave intravascular lithotripsy for calcified coronary lesions: first real-world experience. Heart, Lung and Circulation, 2019, 28: S7-S8.
19. Brinton T J, Ali Z A, Hill J M, et al. Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses: first description. Circulation, 2019, 139(6): 834-836.
20. Kassimis G, Didagelos M, De Maria G L, et al. Shockwave intravascular lithotripsy for the treatment of severe vascular calcification. Angiology, 2020, 71(8): 677-688.
21. Kassimis G, Ziakas A, Didagelos M, et al. Shockwave coronary intravascular lithotripsy system for heavily calcified de novo lesions and the need for a cost-effectiveness analysis. Cardiovascular Revascularization Medicine, 2022, 37: 128-134.
22. Hill J M, Kereiakes D J, Shlofmitz R A, et al. Intravascular lithotripsy for treatment of severely calcified coronary artery disease. Journal of the American College of Cardiology, 2020, 76(22): 2635-2646.
23. Nishida T, Shimokawa H, Oi K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation, 2004, 110(19): 3055-3061.
24. Yang P, Guo T, Wang W, et al. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart and vessels, 2013, 28: 284-291.
25. Wang W, Liu H, Song M, et al. Clinical effect of cardiac shock wave therapy on myocardial ischemia in patients with ischemic heart failure. Journal of cardiovascular pharmacology and therapeutics, 2016, 21(4): 381-387.
26. Zhang Y, Shen T, Liu B, et al. Cardiac shock wave therapy attenuates cardiomyocyte apoptosis after acute myocardial infarction in rats. Cellular Physiology and Biochemistry, 2018, 49(5): 1734-1746.
27. Wang Y, Guo T, Cai H Y, et al. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clinical cardiology, 2010, 33(11): 693-699.
28. Alunni G, Marra S, Meynet I, et al. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina. Cardiovascular Revascularization Medicine, 2015, 16(1): 6-11.
29. Nudi F, Tomai F. Is Cardiac Shock Wave Therapy an Option for the Treatment of Myocardial Ischemia in Patients with Refractory Angina?. Journal of Nuclear Cardiology, 2022, 29(5): 2420-2422.
30. Aissaoui N, Puymirat E, Delmas C, et al. Trends in cardiogenic shock complicating acute myocardial infarction. European Journal of Heart Failure, 2020, 22(4): 664-672.
31. Li Y H, Hsu C Y, Liu C T, et al. Synchronized extracorporeal shockwave lithotripsy may still affect the heart: a case report of perioperative ST-segment elevation myocardial infarction. Frontiers in Medicine, 2023, 10: 1147725.
32. Kereiakes D J, Virmani R, Hokama J Y, et al. Principles of intravascular lithotripsy for calcific plaque modification. Cardiovascular Interventions, 2021, 14(12): 1275-1292.
33. Abe Y, Ito K, Hao K, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circulation Journal, 2014, 78(12): 2915-2925.
34. Kagaya Y, Ito K, Takahashi J, et al. Low-energy cardiac shockwave therapy to suppress left ventricular remodeling in patients with acute myocardial infarction: a first-in-human study. Coronary artery disease, 2018, 29(4): 294-300.
35. Peng Y Z, Guo T, Yang P, et al. Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi, 2012, 40(2): 141-146.
36. Pölzl L, Nägele F, Hirsch J, et al. Defining a therapeutic range for regeneration of ischemic myocardium via shock waves. Scientific Reports, 2021, 11(1): 409.
37. Myojo M, Ando J, Uehara M, et al. Feasibility of extracorporeal shock wave myocardial revascularization therapy for post-acute myocardial infarction patients and refractory angina pectoris patients. International heart journal, 2017, 58(2): 185-190.
38. Holfeld J, Zimpfer D, Albrecht‐Schgoer K, et al. Epicardial shock‐wave therapy improves ventricular function in a porcine model of ischaemic heart disease. Journal of tissue engineering and regenerative medicine, 2016, 10(12): 1057-1064.
39. Jargin S V. Shock wave therapy of ischemic heart disease in the light of general pathology. International journal of cardiology, 2010, 144(1): 116-117.
40. Raza A, Harwood A, Totty J, et al. Extracorporeal shockwave therapy for peripheral arterial disease: a review of the potential mechanisms of action. Annals of vascular surgery, 2017, 45: 294-298.
41. Mariotto S, de Prati A C, Cavalieri E, et al. Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Current medicinal chemistry, 2009, 16(19): 2366-2372.
42. Leu S, Huang T H, Chen Y L, et al. Effect of extracorporeal shockwave on angiogenesis and anti-inflammation: Molecular-cellular signaling pathways[M]//Shockwave Medicine. Karger Publishers, 2018, 6: 109-116.

[Full Text HTML] [Full Text PDF]